Abstract
The mammalian immune system acts to protect the body from harmful diseases ranging from cancer to infection. Differentially expressed proteins as a result of such an immune response can shed light on the mechanism of disease or serve as biomarkers. These biomarkers can be used in a diagnostic capacity or as correlates of protection following vaccination. Protein levels in the circulatory system are considered representative of the system as a whole, making serum an ideal matrix for surveilling immune responses. However, serum proteomics using mass spectrometry is extremely challenging due to the complexity of the matrix and the dynamic range of protein concentration. This chapter will describe two orthogonal enrichment strategies that can be used sequentially or in isolation to improve the identification of low-abundance serum proteins by mass spectrometry.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmed SS, Black S, Ulmer J (2012) New developments and concepts related to biomarker application to vaccines. Microb Biotechnol 5:233–240
Wiederin J, Ciborowski P (2016) Immunoaffinity depletion of highly abundant proteins for proteomic sample preparation. In: Ciborowski P, Silberring J (eds) Proteomic profiling and analytical chemistry, 2nd edn. Elsevier, Boston, pp 101–114
Anderson NL, Anderson NG (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1:845–867
Tirumalai RS, Chan KC, Prieto DA et al (2003) Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics 2:1096–1103
Boschetti E, Righetti PG (2013) Low-abundance proteome discovery: state of the art and protocols. Newnes, Oxford
Di Girolamo F, Boschetti E, Chung MCM et al (2011) “Proteomineering” or not? The debate on biomarker discovery in sera continues. J Proteome 74:589–594
Yocum AK, Yu K, Oe T, Blair IA (2005) Effect of immunoaffinity depletion of human serum during proteomic investigations. J Proteome Res 4:1722–1731
Boschetti E, Righetti PG (2008) The ProteoMiner in the proteomic arena: a non-depleting tool for discovering low-abundance species. J Proteome 71:255–264
Li L (2015) Dynamic range compression with ProteoMiner™: principles and examples. In: Posch A (ed) Proteomic profiling: methods and protocols. Springer, New York, NY, pp 99–107
Murphy S, Dowling P (2018) DIGE analysis of ProteoMiner™ fractionated serum/plasma samples. Methods Mol Biol 1664:109–114
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Moggridge, S., Fulton, K.M., Twine, S.M. (2019). Enriching for Low-Abundance Serum Proteins Using ProteoMiner™ and Protein-Level HPLC. In: Fulton, K., Twine, S. (eds) Immunoproteomics. Methods in Molecular Biology, vol 2024. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9597-4_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9597-4_6
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9596-7
Online ISBN: 978-1-4939-9597-4
eBook Packages: Springer Protocols